The Pharmaceutical Regulatory Affairs in China 2024 is a course dedicated to the key areas of pharmaceutical regulatory affairs in China, Hong Kong, Macau and Taiwan.

Topics

• An overview of import and local manufacture registration
• Drug regulatory systems
• An interpretation of practical aspects
• Clinical product development including CMC regulatory requirements
• The opportunity to exchange experiences with other delegates
• Recent developments

Who should Attend

• Personnel from the following areas
  • Clinical Development
  • Analytical Research and Development
  • New Business Development
  • Quality Assurance
  • Regulatory Authorities
• QScientists and Technical staff in
  • Registration Departments
  • Regulatory Affairs
  • Medical Directors